Skip to content

A comparative study of Dushivishari Agada and Malatyadi taila for treatment of Patchy Hair loss.

A Comparative Trial to Evaluate the Add on Effect of Dushivishari Agada along with Malatyadi Taila in Indralupta with special reference to Alopecia areata - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102885
Enrollment
40
Registered
2026-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L639- Alopecia areata, unspecified

Interventions

None listed

Sponsors

AVANTI AVINASH DHEPE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed patients of Indralupta (Alopecia areata) showing clinical findings as well-circumscribed, bald patches on the scalp. 2. Patient of either gender will be taken. 3. Patients who are willing to participate in the study and ready to give written informed consent

Exclusion criteria

Exclusion criteria: 1. Indralupta covering the scalp in total i.e. Alopecia Totalis and Alopecia Universalis. 2. Patient with other forms of alopecia (for eg. Androgenic alopecia). 3. Cicatricial alopecia patients will be excluded. 4. Patients with other scalp disorders such as tinea capitis, psoriasis,seborrheic dermatitis etc. will be excluded. 5. Patient with endocrine and systemic disorders (eg. Thyroid dysfunction, iron deficiency anemia etc.). 6. Pregnant and lactating females will be excluded. 7. Patients who are unwilling or refuse to participate in the study.

Design outcomes

Primary

MeasureTime frame
1) To study the effect of Dushivishari Agada along with Malatyadi Taila in Indralupta with special reference to Alopecia areata. 2) To study the effect of Malatyadi Taila in Indralupta with special reference to Alopecia areata. 3) To study and compare the add on effect of Dushivishari Agada with Malatyadi Taila and Malatyadi Taila alone in Indralupta with special reference to Alopecia areata.Timepoint: Outcomes will be assessed on at Baseline, 15th day, 30th day, 45th day and 60th day.

Secondary

MeasureTime frame
1) To explore the role of Dushi Visha as a contributory factor in pathogenesis of Indralupta as a Dushivishajanya twacha vikara.Timepoint: 0th, 15th, 30th, 45th, 60th day of trial

Countries

India

Contacts

Public ContactAvanti Avinash Dhepe

Government Ayurved College and Hospital, Nagpur.

drkalpanachavhan@gmail.com9422167952

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026